A comparison of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome

BMC Immunology

Volumn 14, Issue 1, 2013, Pages

  Smylie, Anne Liese ^a   Broderick, Gordon ^a,d   Fernandes, Henrique ^a   Razdan, Shirin ^b   Barnes, Zachary ^b   Collado, Fanny ^c   Sol, Connie ^c,d   Fletcher, Mary Ann ^b   Klimas, Nancy ^c,d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d affiliation with Nova Southeastern College of Osteopathic Medicine   (United States)

Author keywords

Chronic fatigue; Classification model; Cytokines; Exercise challenge; Gulf war illness; Immune signaling

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHEMOLUMINESCENCE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EXERCISE; EXERCISE TEST; FEMALE; GULF WAR ILLNESS; HUMAN; MALE; SEX DIFFERENCE;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; CYTOKINES; FATIGUE SYNDROME, CHRONIC; FEMALE; GULF WAR; HUMANS; MALE; MIDDLE AGED; PERSIAN GULF SYNDROME; SEX CHARACTERISTICS;

EID: 84879221802     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-14-29     Document Type: Article

References (60)

1. Haley RW. Is Gulf War syndrome due to stress? The evidence reexamined. Am J Epidemiol 1997, 146(9):695-703. 10.1093/oxfordjournals.aje.a009343, 9366616.
2. Fukuda K, Nisenbaum R, Stewart G, Thompson WW, Robin L, Washko RM, Noah DL, Barrett DH, Randall B, Herwaldt BL, Mawle AC, Reeves WC. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA 1998, 280:981-998. 10.1001/jama.280.11.981, 9749480.
3. Wolfe J, Proctor SP, Davis JD, Borgos MS, Friedman MJ. Health symptoms reported by Persian Gulf War veterans two years after return. Am J Ind Med 1998, 33(2):104-113. 10.1002/(SICI)1097-0274(199802)33:2<104::AID-AJIM2>3.0.CO;2-Y, 9438043.
4. Kang HK, Natelson BH, Mahan CM, Lee KY, Murphy FM. Post-Traumatic Stress Disorder and Chronic Fatigue Syndrome-like Illness among Gulf War Veterans: A Population-based Survey of 30,000 Veterans. Am J Epidemiol 2003, 157:141-148. 10.1093/aje/kwf187, 12522021.
5. Eisen SA, Kang HK, Murphy FM, Blanchard MS, Reda DJ, Henderson WG, Toomey R, Jackson LW, Alpern R, Parks BJ, Klimas N, Hall C, Pak HS, Hunter J, Karlinsky J, Battistone MJ, Lyons MJ. Gulf War Study Participating Investigators: Gulf War veterans' health: medical evaluation of a US cohort. Ann Int Med 2005, 142:881-890. 10.7326/0003-4819-142-11-200506070-00005, 15941694.
6. Golier JA, Schmeidler J, Legge J, Yehuda R. Enhanced cortisol suppression to dexamethasone associated with Gulf War deployment. Psychoneuroendocrinology 2006, 31(10):1181-1189. 10.1016/j.psyneuen.2006.08.005, 17049422.
7. Golier JA, Schmeidler J, Legge J, Yehuda R. Twenty-four Hour Plasma Cortisol and Adrenocorticotropic Hormone in Gulf War Veterans: Relationships to Posttraumatic Stress Disorder and Health Symptoms. Biol Psychiatry 2007, 62(10):1175-1178. 10.1016/j.biopsych.2007.04.027, 17612507.
8. Unwin C, Blatchley N, Coker W, Ferry S, Hotopf M, Hull L, Ismail K, Palmer I, David A, Wessely S. Health of UK servicemen who served in Persian Gulf War. Lancet 1999, 353:169-178. 10.1016/S0140-6736(98)11338-7, 9923871.
9. Crofford LJ, Young EA, Engleberg NC, Korszun A, Brucksch CB, McClure LA, Brown MB, Demitrack MA. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun 2004, 18:314-325. 10.1016/j.bbi.2003.12.011, 15157948.
10. Johnson JD, O'Connor KA, Watkins LR, Maier SF. The role of IL-1beta in stress-induced sensitization of proinflammatory cytokine and corticosterone responses. Neuroscience 2004, 127(3):569-577. 10.1016/j.neuroscience.2004.05.046, 15283957.
11. Morgan CA, Rasmusson AM, Wang S, Hoyt G, Hauger RL, Hazlett G. Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report. Biol Psychiatry 2002, 52(2):136-142. 10.1016/S0006-3223(02)01319-7, 12114005.
12. Ter Wolbeek M, Van Doornen LJ, Kavelaars A, Van de Putte EM, Schedlowski M, Heijnen CJ. Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents. Brain Behav Immun 2007, 21(8):1063-1074. 10.1016/j.bbi.2007.04.007, 17544255.
13. Skowera A, Cleare A, Blair D, Bevis L, Wessely SC, Peakman M. High levels of type 2 cytokine-producing cells in chronic fatigue syndrome. Clin Exp Immunol 2004, 135(2):294-302. 10.1111/j.1365-2249.2004.02354.x, 1808936, 14738459.
14. Bedoui S, Miyake S, Lin Y, Miyamoto K, Oki S, Kawamura N, Beck-Sickinger A, Von Hörsten S, Yamamura T. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J Immunol 2003, 171(7):3451-3458.
15. Fletcher MA, Rosenthal M, Antoni M, Ironson G, Zeng XR, Barnes Z, Harvey JM, Hurwitz B, Levis S, Broderick G, Klimas NG. Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome. Behav Brain Funct 2010, 6:76. 10.1186/1744-9081-6-76, 3024290, 21190576.
16. Broderick G, Fuite J, Kreitz A, Vernon SD, Klimas N, Fletcher MA. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun 2010, 24(7):1209-1217. 10.1016/j.bbi.2010.04.012, 2939140, 20447453.
17. Moss RB, Mercandetti A, Vojdani A. TNF-alpha and chronic fatigue syndrome. J Clin Immunol 1999, 19(5):314-316. 10.1023/A:1020595709352, 10535608.
18. Gaab J, Rohleder N, Heitz V, Engert V, Schad T, Schürmeyer TH, Ehlert U. Stress-induced changes in LPS-induced proinflammatory cytokine production in chronic fatigue syndrome. Psychoneuroendocrinology 2005, 30(2):188-198. 10.1016/j.psyneuen.2004.06.008, 15471616.
19. Carlo-Stella N, Badulli C, De Silvestri A, Bazzichi L, Martinetti M, Lorusso L, Bombardieri S, Salvaneschi L, Cuccia M. A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles. Clin Exp Rheumatol 2006, 24(2):179-182.
20. Rook GA, Zumla A. Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile?. Lancet 1997, 349(9068):1831-1833. 10.1016/S0140-6736(97)01164-1, 9269228.
21. Zhang Q, Zhou XD, Denny T, Ottenweller JE, Lange G, LaManca JJ, Lavietes MH, Pollet C, Gause WC, Natelson BH. Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome. Clin Diagn Lab Immunol 1999, 6(1):6-13. 95652, 9874656.
22. Skowera A, Hotopf M, Sawicka E, Varela-Calvino R, Unwin C, Nikolaou V, Hull L, Ismail K, David AS, Wessely SC, Peakman M. Cellular immune activation in Gulf War veterans. J Clin Immunol 2004, 24(1):66-73.
23. Allen JS, Skowera A, Rubin GJ, Wessely S, Peakman M. Long-lasting T cell responses to biological warfare vaccines in human vaccinees. Clin Infect Dis 2006, 43(1):1-7. 10.1086/504806, 16758411.
24. Brimacombe M, Zhang Q, Lange G, Natelson BH. Immunological variables mediate cognitive dysfunction in gulf war veterans but not civilians with chronic fatigue syndrome. Neuroimmunomodulation 2002, 10(2):93-100. 10.1159/000065185, 12372983.
25. Broderick G, Kreitz A, Fuite J, Fletcher MA, Vernon SD, Klimas N. A pilot study of immune network remodeling under challenge in Gulf War Illness. Brain Behav Immun 2011, 25(2):302-313. 10.1016/j.bbi.2010.10.011, 20955779.
26. Peakman M, Skowera A, Hotopf M. Immunological dysfunction, vaccination and Gulf War illness. Philos Trans R Soc Lond B Biol Sci 2006, 361(1468):681-687. 10.1098/rstb.2006.1826, 1569620, 16687270.
27. Butts CL, Sternberg EM. Neuroendocrine factors alter host defense by modulating immune function. Cell Immunol 2008, 252(1-2):7-15. 2590632, 18329009.
28. Broderick G, Fletcher MA, Gallagher M, Barnes Z, Vernon SD, Klimas NG. Exploring the Diagnostic Potential of Immune Biomarker Coexpression in Gulf War Illness. Psychoneuroimmunology: Methods and Protocols, Part II, Chap. 8/Methods in Molecular Biology, vol 934 2012, 145-164. New York: Springer, Yan Q, Walker JM.
29. Verreck FA, De Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, De Waal-Malefyt R, Ottenhoff TH. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 2004, 101(13):4560-5. 10.1073/pnas.0400983101, 384786, 15070757.
30. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev 2008, 223:87-113. 10.1111/j.1600-065X.2008.00628.x, 3299089, 18613831.
31. Reeves WC, Lloyd A, Vernon SD, Klimas N, Jason LA, Bleijenberg G, Evengard B, White PD, Nisenbaum R, Unger ER. International Chronic Fatigue Syndrome Study Group Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res 2003, 3(1):25. 10.1186/1472-6963-3-25, 317472, 14702202, International Chronic Fatigue Syndrome Study Group.
32. Collins JF, Donta ST, Engel CC, Baseman JB, Dever LL, Taylor T, Boardman KD, Martin SE, Wiseman AL: Feussner JR, Feussner AL. The antibiotic treatment trial of Gulf War Veterans' Illnesses: issues, design, screening, and baseline characteristics. Control Clin Trials 2002, 23(3):333-353. 10.1016/S0197-2456(02)00192-7, 12057884.
33. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. International Chronic Fatigue Syndrome Study Group The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994, 12:953-959. International Chronic Fatigue Syndrome Study Group.
34. World Health Organization Composite Interview Diagnostic Interview (CIDI core), version 2.1 1997, World Health Organization: Geneva, World Health Organization.
35. McArdle WD, Katch FI, Katch VL. Exercise Physiology: Energy, Nutrition, and Human Performance 2007, London: Lippincott Williams & Wilkins.
36. Fletcher MA, Zeng XR, Barnes Z, Levis S, Klimas NG. Plasma cytokines in women with chronic fatigue syndrome. J Transl Med 2009, 7:96. 10.1186/1479-5876-7-96, 2779802, 19909538.
37. Frankenstein Z, Alon U, Cohen IR. The immune-body cytokine network defines a social architecture of cell interactions. Biol Direct 2006, 1:32. 10.1186/1745-6150-1-32, 1636025, 17062134.
38. Rawlings JO. ollinearity Diagnostics. Applied Regression Analysis 1988, 273-281. Pacific Grove: Wadsworth and Brooks, Barndorff-Nielsen OE, Bickel PJ, Cleveland WS, Dudley RM.
39. Draper NR, Smith H. Stepwise Regression. Applied Regression Analysis 1998, 307-312. Hoboken, NJ: Wiley-Interscience.
40. Krzanowski WJ. Reduction of dimensionality: Inferential aspects of descriptive methods. Principles of Multivariate Analysis: A User's Perspective. Chap. 9 1988, 252-264. Oxford: Oxford University Press, Oxford Statistical Science Series, Atkinson AC, Copas JB, Pierce DA, Schervish MJ, Titterington DM.
41. Pedersen BK, Akerström TC, Nielsen AR, Fischer CP. Role of myokines in exercise and metabolism. J Appl Physiol 2007, 103(3):1093-1098. 10.1152/japplphysiol.00080.2007, 17347387.
42. Brandt C, Pedersen BK. The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases. J Biomed Biotechnol 2010, 2010:520258. 10.1155/2010/520258 Epub 2010 Mar 9., 2836182, 20224659.
43. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, Blank RB, Meylan F, Siegel R, Hennighausen L, Shevach EM, O'shea JJ. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26(3):371-381. 10.1016/j.immuni.2007.02.009, 17363300.
44. Liu FL, Chen CH, Chu SJ, Chen JH, Lai JH, Sytwu HK, Chang DM. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway. Rheumatology (Oxford) 2007, 46(8):1266-1273.
45. Hughes GC. Progesterone and autoimmune disease. Autoimmun Rev 2012, 11(6-7):A502-514. Review, 3431799, 22193289.
46. Zhang MA, Rego D, Moshkova M, Kebir H, Chruscinski A, Nguyen H, Akkermann R, Stanczyk FZ, Prat A, Steinman L, Dunn SE. Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way. Proc Natl Acad Sci USA 2012, 109(24):9505-9510. 10.1073/pnas.1118458109, 3386070, 22647601.
47. Gomez A, Luckey D, Yeoman CJ, Marietta EV, Berg Miller ME, Murray JA, White BA, Taneja V. Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS One 2012, 7(4):e36095. 10.1371/journal.pone.0036095, 3338357, 22553482.
48. Amourette C, Lamproglou I, Barbier L, Fauquette W, Zoppe A, Viret R, Diserbo M. Gulf War illness: Effects of repeated stress and pyridostigmine treatment on blood-brain barrier permeability and cholinesterase activity in rat brain. Behav Brain Res 2009, 203(2):207-214. 10.1016/j.bbr.2009.05.002, 19433115.
49. Barbier L, Diserbo M, Lamproglou I, Amourette C, Peinnequin A, Fauquette W. Repeated stress in combination with pyridostigmine Part II: changes in cerebral gene expression. Behav Brain Res 2009, 197(2):292-300. 10.1016/j.bbr.2008.08.032, 18796314.
50. Guiñazú N, Rena V, Genti-Raimondi S, Rivero V, Magnarelli G. Effects of the organophosphate insecticides phosmet and chlorpyrifos on trophoblast JEG-3 cell death, proliferation and inflammatory molecule production. Toxicol In Vitro 2012, 26(3):406-413. 10.1016/j.tiv.2012.01.003, 22265773.
51. Kawashima K, Fujii T. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci 2003, 74(6):675-696. Review, 10.1016/j.lfs.2003.09.037, 14654162.
52. Qian J, Galitovskiy V, Chernyavsky AI, Marchenko S, Grando SA. Plasticity of the murine spleen T-cell cholinergic receptors and their role in in vitro differentiation of naïve CD4 T cells toward the Th1, Th2 and Th17 lineages. Genes Immun 2011, 12(3):222-230. 10.1038/gene.2010.72, 21270829.
53. Profita M, Bonanno A, Siena L, Ferraro M, Montalbano AM, Pompeo F, Riccobono L, Pieper MP, Gjomarkaj M. Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism. Eur J Pharmacol 2008, 582(1-3):145-153.
54. Kashiwagi Y, Yanagita M, Kojima Y, Shimabukuro Y, Murakami S. Nicotine up-regulates IL-8 expression in human gingival epithelial cells following stimulation with IL-1β or P. gingivalis lipopolysaccharide via nicotinic acetylcholine receptor signalling. Arch Oral Biol 2012, 57(5):483-490. 10.1016/j.archoralbio.2011.10.007, 22119045.
55. Broderick G, Ben-Hamo R, Vashishtha S, Efroni S, Nathanson L, Barnes Z, Fletcher MA, Klimas N. Altered immune pathway activity under exercise challenge in Gulf War Illness: an exploratory analysis. Brain Behav Immun 2013, 28:159-169.
56. Cioffi M, Esposito K, Vietri MT, Gazzerro P, D'Auria A, Ardovino I, Puca GA, Molinari AM. Cytokine pattern in postmenopause. Maturitas 2002, 41(3):187-192. 10.1016/S0378-5122(01)00286-9, 11886764.
57. Goetzl EJ, Huang MC, Kon J, Patel K, Schwartz JB, Fast K, Ferrucci L, Madara K, Taub DD, Longo DL. Gender specificity of altered human immune cytokine profiles in aging. FASEB J 2010, 24(9):3580-3589. 10.1096/fj.10-160911, 2923363, 20453111.
58. Silverman MN, Pearce BD, Biron CA, Miller AH. Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol 2005, 18(1):41-78. Review, 10.1089/vim.2005.18.41, 1224723, 15802953.
59. Mascanfroni I, Montesinos Mdel M, Susperreguy S, Cervi L, Ilarregui JM, Ramseyer VD, Masini-Repiso AM, Targovnik HM, Rabinovich GA, Pellizas CG. Control of dendritic cell maturation and function by triiodothyronine. FASEB J 2008, 22(4):1032-1042.
60. Cleare AJ. The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 2003, 24(2):236-252.